US9174999, Table 1, Compound 3::US9174999, Table 1, Compound 4

ID: ALA3896454

Chembl Id: CHEMBL3896454

PubChem CID: 60135375

Max Phase: Preclinical

Molecular Formula: C16H27N7O4

Molecular Weight: 381.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C1N[C@H]2[C@H](COC(=O)NC3CCCCC3)NC(=N)N3CCC(O)(O)[C@]23N1

Standard InChI:  InChI=1S/C16H27N7O4/c17-12-21-11-10(8-27-14(24)19-9-4-2-1-3-5-9)20-13(18)23-7-6-15(25,26)16(11,23)22-12/h9-11,25-26H,1-8H2,(H2,18,20)(H,19,24)(H3,17,21,22)/t10-,11-,16-/m0/s1

Standard InChI Key:  DMNGGGFGCGRWLA-MMPTUQATSA-N

Associated Targets(Human)

SCN4A Tclin Sodium channel protein type IV alpha subunit (583 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Scn4a Sodium channel protein type IV alpha subunit (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.44Molecular Weight (Monoisotopic): 381.2125AlogP: -1.47#Rotatable Bonds: 3
Polar Surface Area: 165.82Molecular Species: BASEHBA: 6HBD: 8
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.76CX Basic pKa: 9.06CX LogP: -0.22CX LogD: -2.88
Aromatic Rings: Heavy Atoms: 27QED Weighted: 0.27Np Likeness Score: 1.22

References

1.  (2015)  Methods and compositions for studying, imaging, and treating pain, 

Source

Source(1):